Saliva: Physiology and diagnostic potential in health and disease

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 434-456

  Farnaud, Sebastien J C ^a,b   Kosti, Ourania ^c   Getting, Stephen J ^a   Renshaw, Derek ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b Dr Hadwen Trust for Humane Research   (United Kingdom)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Biomarkers; Diagnostic markers; Oral disease; Saliva

Indexed keywords

ADRENOMEDULLIN; BIOLOGICAL MARKER; CALGRANULIN; CATHELICIDIN; DEFENSIN; HISTATIN; HYDROCORTISONE; LACTOFERRIN; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; BLOOD SAMPLING; CANCER DIAGNOSIS; CHEMICAL COMPOSITION; COMMUNICABLE DISEASE; DEVICE; DIAGNOSTIC VALUE; FOOD INTAKE; HEALTH CARE COST; HORMONAL REGULATION; HUMAN; IMMUNITY; MOUTH CANCER; MOUTH CAVITY; MOUTH DISEASE; PHYSIOLOGY; REVIEW; SALIVA; SALIVA ANALYSIS; SALIVATION; SATIETY; SYSTEMIC DISEASE; TISSUE REPAIR;

BIOLOGICAL MARKERS; DIAGNOSIS; HUMANS; SALIVA;

EID: 77951701595     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.38     Document Type: Review

References (218)

1. th ed. Benjamin Cummings.
2. th ed. Benjamin Cummings.
3. Kaufman, E. and Lamster, I.B. (2002) The diagnostic applications of saliva - a review. Crit. Rev. Oral Biol. Med. 13, 197-212.
4. Vining, R.F., McGinley, R.A., and Symons, R.G. (1983) Hormones in saliva: mode of entry and consequent implications for clinical interpretation. Clin. Chem. 29, 1752-1756.
5. Mandel, I.D. (1989) The role of saliva in maintaining oral homeostasis. J. Am. Dent. Assoc. 119, 298-304.
6. Amerongen, A. van N., Veerman E.C.I., and Vissink, A. (2008) Saliva: properties and function. In Salivary Diagnostics. Wong, D.T., Ed. Wiley-Blackwell. Chap. 3.
7. Ellison, S.A., Massimo, P.A., and Mandel, I.D. (1960) Immunochemical studies of human saliva. I. The demonstration of serum proteins in whole and parotid saliva. J. Dent. Res. 39, 892-898.
8. Hanson, L.A. and Brandtzaeg, P. (1993) The discovery of secretory IgA and the mucosal immune system. Immunol. Today 14, 416-417. (Pubitemid 23226230)
9. Tomasi, T.B., Jr., Tan, E.M., Solomon, A., and Prendergast, R.A. (1965) Characteristics of an immune system common to certain external secretions. J. Exp. Med. 121, 101-124.
10. Brandtzaeg, P. (1973) Two types of IgA immunocytes in man. Nat. New Biol. 243, 142-143.
11. Brandtzaeg, P. (1974) Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique. Immunology 26, 1101-1114.
12. Brandtzaeg, P. (2003) Role of secretory antibodies in the defence against infections. Int. J. Med. Microbiol. 293, 3-15.
13. Phalipon, A. and Corthésy, B. (2003) Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins. Trends Immunol. 24, 55-58. (Pubitemid 36120638)
14. Brandtzaeg, P., Fjellanger, I., and Gjeruldsen, S.T. (1968) Immunoglobulin M: local synthesis and selective secretion in patients with immunoglobulin A deficiency. Science 160, 789-791.
15. Brandtzaeg, P. (2007) Do salivary antibodies reliably reflect both mucosal and systemic immunity? Ann. N. Y. Acad. Sci. 1098, 288-311.
16. Schenkels, L.C., Veerman, E.C., and Nieuw Amerongen, A.V. (1995) Biochemical composition of human saliva in relation to other mucosal fluids. Crit. Rev. Oral Biol. Med. 6, 161-175.
17. Nagler, R.M. (2004) Salivary glands and the aging process: mechanistic aspects, health-status and medicinal-efficacy monitoring. Biogerontology 5, 223-233.
18. Denny, P.C. and Denny, P.A. (2008) Dental caries risk assessment. In Salivary Diagnostics. Wong, D.T., Ed. Wiley-Blackwell. Chap. 14.
19. Edgar, W.M. (1992) Saliva: its secretion, composition and functions. Br. Dent. J. 172, 305-312.
20. Humphrey, S.P. and Williamson, R.T. (2001) A review of saliva: normal composition, flow, and function. J. Prosthet. Dent. 85, 162-169.
21. Hancock, R.E. and Lehrer, R. (1998) Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16, 82-88.
22. Boman, H.G., Nilsson, I., and Rasmuson, B. (1972) Inducible antibacterial defence system in Drosophila. Nature 237, 232-235.
23. Hultmark, D., Steiner, H., Rasmuson, T., and Boman, H.G. (1980) Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur. J. Biochem. 106, 7-16. (Pubitemid 10057882)
24. Selsted, M.E., Brown, D.M., DeLange, R.J., and Lehrer, R.I. (1983) Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. J. Biol. Chem. 258(23), 14485-14489.
25. Lai, R., Liu, H., Hui Lee, W., and Zhang, Y. (2002) An anionic antimicrobial peptide from toad Bombina maxima. Biochem. Biophys. Res. Commun. 295, 796-799.
26. Papagianni, M. (2003) Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. Biotechnol. Adv. 21, 465-499.
27. Sitaram, N. and Nagaraj, R. (2002) Host-defense antimicrobial peptides: importance of structure for activity. Curr. Pharm. Des. 8, 727-742. (Pubitemid 34498562)
28. Brogden, K.A. (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238-250.
29. Farnaud, S., Spiller, C., Moriarty, L.C., Patel, A., Gant, V., Odell, E.W., and Evans, R.W. (2004) Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. FEMS Microbiol. Lett. 233, 193-199. (Pubitemid 38452620)
30. Farnaud, S. and Evans, R.W. (2003) Lactoferrin - a multifunctional protein with antimicrobial properties. Mol. Immunol. 40, 395-405. (Pubitemid 37244032)
31. Marchand, C., Krajewski, K., Lee, H.F., Antony, S., Johnson, A.A., Amin, R., Roller, P., Kvaratskhelia, M., and Pommier, Y. (2006) Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucleic Acids Res. 34, 5157-5165. (Pubitemid 44742480)
32. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R.A., Pestonjamasp, V., Piraino, J., Huttner, K., and Gallo, R.L. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457. (Pubitemid 34173727)
33. Turner, J., Cho, Y., Dinh, N.N., Waring, A.J., and Lehrer, R.I. (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42, 2206-2214. (Pubitemid 28420351)
34. Yasin, B., Pang, M., Turner, J.S., Cho, Y., Dinh, N.N., Waring, A.J., Lehrer, R.I., and Wagar, E.A. (2000) Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Eur. J. Clin. Microbiol. Infect. Dis. 19, 187-194. (Pubitemid 30201294)
35. Nagaoka, I., Hirota, S., Yomogida, S., Ohwada, A., and Hirata, M. (2000) Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm. Res. 49, 73-79. (Pubitemid 30123847)
36. Zanetti, M. (2004) Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 39-48.
37. De, Y., Chen, Q., Schmidt, A.P., Anderson, G.M., Wang, J.M., Wooters, J., Oppenheim, J.J., and Chertov, O. (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192, 1069-1074.
38. Niyonsaba, F., Someya, A., Hirata, M., Ogawa, H., and Nagaoka, I. (2001) Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol. 31, 1066-1075.
39. Niyonsaba, F., Iwabuchi, K., Someya, A., Hirata, M., Matsuda, H., Ogawa, H., and Nagaoka, I. (2002) A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106, 20-26. (Pubitemid 34437873)
40. Scott, M.G., Davidson, D.J., Gold, M.R., Bowdish, D., and Hancock, R.E. (2002) The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169, 3883-3891.
41. Putsep, K., Carlsson, G., Boman, H.G., and Andersson, M. (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360, 1144-1149. (Pubitemid 35246490)
42. Kostmann, R. (1956) Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr. Suppl. 45(Suppl 105), 1-78.
43. Carlsson, G. and Fasth, A. (2001) Infantile genetic agranulocytosis, morbus Kostmann: presentation of six cases from the original "Kostmann family" and a review. Acta Paediatr. 90, 757-764.
44. Lehrer, R.I. and Ganz, T. (2002) Defensins of vertebrate animals. Curr. Opin. Immunol. 14, 96-102.
45. Liu, L., Zhao, C., Heng, H.H., and Ganz, T. (1997) The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics 43, 316-320. (Pubitemid 27353707)
46. Yang, D., Biragyn, A., Kwak, L.W., and Oppenheim, J.J. (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23, 291-296. (Pubitemid 34628771)
47. Befus, A.D., Mowat, C., Gilchrist, M., Hu, J., Solomon, S., and Bateman, A. (1999) Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J. Immunol. 163, 947-953. (Pubitemid 29328106)
48. Prohaszka, Z., Nemet, K., Csermely, P., Hudecz, F., Mezo, G., and Fust, G. (1997) Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV-1. Mol. Immunol. 34, 809-816. (Pubitemid 28044553)
49. Schonwetter, B.S., Stolzenberg, E.D. and Zasloff, M.A. (1995) Epithelial antibiotics induced at sites of inflammation. Science 267, 1645-1648.
50. Mathews, M., Jia, H.P., Guthmiller, J.M., Losh, G., Graham, S., Johnson, G.K., Tack, B.F., and McCray, P.B., Jr. (1999) Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect. Immun. 67, 2740-2745.
51. Mizukawa, N., Sugiyama, K., Ueno, T., Mishima, K., Takagi, S., and Sugahara, T. (1999) Levels of human defensin-1, an antimicrobial peptide, in saliva of patients with oral inflammation. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 87, 539-543.
52. Abiko, Y., Mitamura, J., Nishimura, M., Muramatsu, T., Inoue, T., Shimono, M., and Kaku, T. (1999) Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett. 143, 37-43. (Pubitemid 29327187)
53. Krisanaprakornkit, S., Weinberg, A., Perez, C.N., and Dale, B.A. (1998) Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect. Immun. 66, 4222-4228. (Pubitemid 28402695)
54. Krisanaprakornkit, S., Kimball, J.R., Weinberg, A., Darveau, R.P., Bainbridge, B.W., and Dale, B.A. (2000) Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 68, 2907-2915. (Pubitemid 30253871)
55. Dale, B.A., Kimball, J.K., Krisanaprakornkit, S., Roberts, K., Robinovitch, M., O'Neal, R., Valore, E.V., Ganz, T., Anderson, G.M., and Weinberg, A. (2002) Localized antimicrobial peptide expression in human gingival. J. Periodontal Res. 36, 285-294.
56. Dave, S., Batista, E.L., Jr., and Van Dyke, T.E. (2004) Cardiovascular disease and periodontal diseases: commonality and causation. Compend. Contin. Educ. Dent. 25, 26-37.
57. Tonetti, M.S., Imboden, M.A., and Lang, N.P. (1998) Neutrophil migration into the gingival sulcus is associated with transepithelial gradients of interleukin-8 and ICAM-1. J. Periodontol. 69, 1139-1147.
58. Bevins, C.L., Martin-Porter, E., and Ganz, T. (1999) Defensins and innate host defence of the gastrointestinal tract. Gut 45, 911-915.
59. Kapas, S., Bansal, A., Bhargava, V., Maher, R., Malli, D., Hagi-Pavli, E., and Allaker, R.P. (2001) Adrenomedullin expression in pathogen-challenged oral epithelial cells. Peptides 22, 1485-1489. (Pubitemid 32770022)
60. Allaker, R.P., Zihni, C., and Kapas, S. (1999) An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. FEMS Immunol. Med. Microbiol. 23, 289-293. (Pubitemid 29164438)
61. Caron, K.M. and Smithies, O. (2001) Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. Proc. Natl. Acad. Sci. U. S. A. 98, 615-619.
62. Troxler, R.F., Offner, G.D., Xu, T., Vanderspek, J.C., and Oppenheim, F.G. (1990) Structural relationship between human salivary histatins. J. Dent. Res. 69, 2-6.
63. Lupi, A., Schinina, M.E., Denotti, G., Fadda, M.B., Piras, V., Patamia, M., Cordaro, M., Isola, M., and Messana, I. (2003) Human salivary peptides derived from histatins. Eur. J. Morphol. 41, 99-102. (Pubitemid 40050912)
64. Oppenheim, F.G., Yang, Y.C., Diamond, R.D., Hyslop, D., Offner, G.D., and Troxler, R.F. (1986) The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion. J. Biol. Chem. 261, 1177-1182.
65. Oppenheim, F.G., Xu, T., McMillian, F.M., Levitz, S.M., Diamond, R.D., Offner, G.D., and Troxler, R.F. (1988) Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J. Biol. Chem. 263, 7472-7477.
66. Sorensen, M. and Sorensen, S.P.L. (1939) The proteins in whey. C. R. Trav. Lab. Carlsberg Ser. Chim. 25, 55.
67. Farnaud, S. and Evans, R.W. (2005) Lactoferrin: the conductor of the immunological system? In New Research on Immunology. Veskler, B.A., Ed. Nova Science Publishers. pp. 47-76.
68. Tabak, L., Mandel, I.D., Karlan, D., and Baurmash, H. (1978) Alterations in lactoferrin in salivary gland disease. J. Dent. Res. 57, 43-47. (Pubitemid 8385867)
69. Singh, P.K. (2004) Iron sequestration by human lactoferrin stimulates P. aeruginosa surface motility and blocks biofilm formation. Biometals 17, 267-270.
70. Gray-Owen, S.D. and Schryvers, A.B. (1996) Bacterial transferrin and lactoferrin receptors. Trends Microbiol. 4, 185-191.
71. Russo-Mancuso, G., Branciforte, F., Licciardello, M., and La Spina, M. (2003) Iron deficiency anemia as the only sign of infection with Helicobacter pylori: a report of 9 pediatric cases. Int. J. Hematol. 78, 429-431. (Pubitemid 37549622)
72. Kalmar, J.R. and Arnold, R.R. (1988) Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect. Immun. 56, 2552-2557.
73. Fine, D.H., Furgang, D., and Beydouin, F. (2002) Lactoferrin iron levels are reduced in saliva of patients with localized aggressive periodontitis. J. Periodontol. 73, 624-630. (Pubitemid 34679076)
74. Bellamy, W., Takase, M., Wakabayashi, H., Kawase, K., and Tomita, M. (1992) Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 73, 472-479. (Pubitemid 23160081)
75. Ross, K.F. and Herzberg, M.C. (2001) Calprotectin expression by gingival epithelial cells. Infect. Immun. 69, 3248-3254. (Pubitemid 32332223)
76. Dagogo-Jack, S. (1986) Epidermal growth factor EGF in human saliva: effect of age, sex, race, pregnancy and sialogogue. Scand. J. Gastroenterol. Suppl. 124, 47-54.
77. Wang, S.L., Milles, M., Wu-Wang, C.Y., Liu, J., Slomiany, A., and Slomiany, B.L. (1990) Identification of epidermal growth factor receptor in human buccal mucosa. Arch. Oral Biol. 35, 823-828.
78. Thesleff, I., Viinikka, L., Saxén, L., Lehtonen, E., and Perheentupa, J. (1988) The parotid gland is the main source of human salivary epidermal growth factor. Life Sci. 43, 13-18.
79. Xu, T., Levitz, S.M., Diamond, R.D., and Oppenheim, F.G. (1991) Anticandidal activity of major human salivary histatins. Infect. Immun. 59, 2549-2554.
80. Oudhoff, M.J., Bolscher, J.G., Nazmi, K., Kalay, H., van 't Hof, W., Amerongen, A.V., and Veerman, E.C. (2008) Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. FASEB J. 22, 3805-3812.
81. Oudhoff, M.J, Kroeze, K.L., Nazmi, K., van den Keijbus, P.A., van 't Hof, W., Fernandez-Borja, M., Hordijk, P.L., Gibbs, S., Bolscher, J.G., and Veerman, E.C. (2009). Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1000-fold. FASEB J. 23, 3928-3935.
82. Turner-Cobb, J.M., Rixon, L., and Jessop, D.S. (2008) A prospective study of diurnal cortisol responses to the social experience of school transition in four-year-old children: anticipation, exposure, and adaptation. Dev. Psychobiol. 50, 377-389.
83. Major, C.J., Read, S.E., Coates, R.A., Francis, A., McLaughlin, B.J., Millson, M., Shepherd, F., Fanning, M., Calzavara, L., and MacFadden, D. (1991) Comparison of saliva and blood for human immunodeficiency virus prevalence testing. J. Infect. Dis. 163, 699-702.
84. Thorn, L., Hucklebridge, F., Evans, P., and Clow, A. (2009) The cortisol awakening response, seasonality, stress and arousal: a study of trait and state influences. Psychoneuroendocrinology 34, 299-306.
85. Stalder, T., Evans, P., Hucklebridge, F., and Clow, A. (2009) Associations between psychosocial state variables and the cortisol awakening response in a single case study. Psychoneuroendocrinology 35, 209-214.
86. Ramseier, C.A., Morelli, T., Kinney, J.S., Dubois, M., Rayburn, L., and Giannobile, W. (2008) Periodontal disease. In Salivary Diagnostics. Wong, D.T., Ed. Wiley-Blackwell. Chap. 15.
87. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108.
88. Franceschi, S., Talamini, R., Barra, S., Baron, A.E., Negri, E., Bidoli, E., Serraino, D., and La Vecchia, C. (1990) Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res. 50, 6502-6507. (Pubitemid 20348768)
89. Mashberg, A., Boffetta, P., Winkelman, R., and Garfinkel, L. (1993) Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 72, 1369-1375. (Pubitemid 23225011)
90. Herrero, R., Castellsague, X., Pawlita, M., Lissowska, J., Kee, F., Balaram, P., Rajkumar, T., Sridhar, H., Rose, B., Pintos, J., Fernandez, L., Idris, A., et al. (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J. Natl. Cancer Inst. 95, 1772-1783.
91. Gillison, M.L., Koch, W.M., Capone, R.B., Spafford, M., Westra, W.H., Wu, L., Zahurak, M.L., Daniel, R.W., Viglione, M., Symer, D.E., Shah, K.V., and Sidransky, D. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92, 709-720.
92. Hunter, K.D., Parkinson, E.K., and Harrison, P.R. (2005) Profiling early head and neck cancer. Nat. Rev. Cancer 5, 127-135.
93. Loree, T.R. and Strong, E.W. (1990) Significance of positive margins in oral cavity squamous carcinoma. Am. J. Surg. 160, 410-414.
94. Thomson, P.J. and Wylie, J. (2002) Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management. Int. J. Oral. Maxillofac. Surg. 31(2), 145-153.
95. Field, J.K., Pavelic, Z.P., Spandidos, D.A., Stambrook, P.J., Jones, A.S., and Gluckman, J.L. (1993) The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 119(10), 1118-1122.
96. Boyle, J.O., Hakim, J., Koch, W., van der Riet, P., Hruban, R.H., Roa, R.A., Correo, R., Eby, Y.J., Ruppert, J.M., and Sidransky, D. (1993) The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 53(19), 4477-4480.
97. Brennan, J.A., Boyle, J.O., Koch, W.M., Goodman, S.N., Hruban, R.H., Eby, Y.J., Couch, M.J., Forastiere, A.A., and Sidransky, D. (1995) Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 332(11), 712-717.
98. Boyle, J.O., Mao, L., Brennan, J.A., Koch, W.M., Eisele, D.W., Saunders, J.R., and Sidransky, D. (1994) Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am. J. Surg. 168(5), 429-432.
99. Hainaut, P., Soussi, T., Shomer, B., Hollstein, M., Greenblatt, M., Hovig, E., Harris, C.C., and Montesano, R. (1997) Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res. 25(1), :151-157.
100. Ogden, G.R., Kiddie, R.A., Lunny, D.P., and Lane, D.P. (1992) Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J. Pathol. 166(4), 389-394.
101. Crawford, L.V., Pim, D.C., and Bulbrook, R.D. (1982) Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int. J. Cancer 30(4), 403-408.
102. Davidoff, A.M., Iglehart, J.D., and Marks, J.R. (1992) Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc. Natl. Acad. Sci. U. S. A. 89(8), 3439-3442.
103. Wild, C.P., Ridanpaa, M., Anttila, S., Lubin, R., Soussi, T., Husgafvel-Pursiainen, K., and Vainio, H. (1995) p53 antibodies in the sera of lung cancer patients: comparison with p53 mutation in the tumour tissue. Int. J. Cancer 64(3), 176-181.
104. Lubin, R., Zalcman, G., Bouchet, L., Tredanel, J., Legros, Y., Cazals, D., Hirsch, A., and Soussi, T. (1995) Serum p53 antibodies as early markers of lung cancer. Nat. Med. 1(7), 701-702.
105. Lubin, R., Schlichtholz, B., Teillaud, J.L., Garay, E., Bussel, A., and Wild, C.P. (1995) p53 antibodies in patients with various types of cancer: assay, identification, and characterization. Clin. Cancer Res. 1(12), 1463-1469.
106. Ralhan, R., Nath, N., Agarwal, S., Mathur, M., Wasylyk, B., and Shukla, N.K. (1998) Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations. Clin. Cancer Res. 4(9), 2147-2152.
107. Sainger, R.N., Shah, M.H., Desai, A.A., Shukla, S.N., Shah, P.M., Telang, S.D., and Patel, P.S. (2006) Clinical significance of serum p53 antibodies in oral cancer. Tumori 92(2), 134-139.
108. Bourhis, J., Lubin, R., Roche, B., Koscielny, S., Bosq, J., Dubois, I., Talbot, M., Marandas, P., Schwaab, G., Wibault, P., Luboinski, B., Eschwege, F., et al. (1996) Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma. J. Natl. Cancer Inst. 88(17), 1228-1233. (Pubitemid 26302037)
109. Tavassoli, M., Brunel, N., Maher, R., Johnson, N.W., and Soussi, T. (1998) p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int. J. Cancer 78(3), 390-391. (Pubitemid 28445381)
110. Liao, P.H., Chang, Y.C., Huang, M.F., Tai, K.W., and Chou, M.Y. (2000) Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. Oral Oncol. 36(3), 272-276.
111. Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W., and Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature 389(6648), 300-305.
112. Ravi, D., Nalinakumari, K.R., Rajaram, R.S., Nair, M.K., and Pillai, M.R. (1996) Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions. Cancer Lett. 105(2), 139-146.
113. Gibson, S.A., Pellenz, C., Hutchison, R.E., Davey, F.R., and Shillitoe, E.J. (2000) Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector. Clin. Cancer Res. 6(1), 213-222.
114. Tian, X.X., Chan, J.Y., Pang, J.C., Chen, J., He, J.H., To, T.S., Leung, S.F., and Ng, H.K. (1999) Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor. Br. J. Cancer 81(6), 994-1001.
115. Weaver, L.T., Gonnella, P.A., Israel, E.J., and Walker, W.A. (1990) Uptake and transport of epidermal growth factor by the small intestinal epithelium of the fetal rat. Gastroenterology 98(4), 828-837.
116. Balicki, R., Grabowska, S.Z., and Citko, A. (2005) Salivary epidermal growth factor in oral cavity cancer. Oral Oncol. 41(1), 48-55.
117. Rubin, G.J., Melhem, M.F., Barnes, E.L., and Tweardy, D.J. (1996) Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 78(6), 1284-1292.
118. Todd, R., Donoff, B.R., Gertz, R., Chang, A.L., Chow, P., Matossian, K., McBride, J., Chiang, T., Gallagher, G.T., and Wong, D.T. (1989) TGF-alpha and EGF-receptor mRNAs in human oral cancers. Carcinogenesis 10(8), 1553-1556.
119. Faust, R.A., Tawfic, S., Davis, A.T., and Ahmed, K. (1999) Apoptosis and growth inhibition of head and neck tumor cell line induced by epidermal growth factor receptor tyrosine kinase inhibitor. Oral Oncol. 35(3), 290-295.
120. He, Y., Zeng, Q., Drenning, S.D., Melhem, M.F., Tweardy, D.J., Huang, L., and Grandis, J.R. (1998) Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter. J. Natl. Cancer Inst. 90(14), 1080-1087.
121. Wang, S.L., Milles, M., Wu-Wang, C.Y., Mardirossian, G., Leung, C., Slomiany, A., and Slomiany, B.L. (1992) Effect of cigarette smoking on salivary epidermal growth factor (EGF) and EGF receptor in human buccal mucosa. Toxicology 75(2), 145-157.
122. Galloway, D.A. and McDougall, J.K. (1996) The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia. Semin. Cancer Biol. 7(6), 309-315.
123. Sugerman, P.B. and Shillitoe, E.J. (1997) The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Dis. 3(3), 130-147.
124. Shin, K.H., Min, B.M., Cherrick, H.M., and Park, N.H. (1994) Combined effects of human papillomavirus-18 and N-methyl-N′-nitro-N- nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol. Carcinog. 9(2), 76-86.
125. Park, N.H., Li, S.L., Xie, J.F., and Cherrick, H.M. (1992) In vitro and animal studies of the role of viruses in oral carcinogenesis. Eur. J. Cancer B Oral Oncol. 28B(2), 145-152.
126. Smith, E.M., Ritchie, J.M., Summersgill, K.F., Klussmann, J.P., Lee, J.H., Wang, D., Haugen, T.H., and Turek, L.P. (2004) Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int. J. Cancer 108(5), 766-772.
127. Gillison, M.L., Koch, W.M., Capone, R.B., Spafford, M., Westra, W.H., Wu, L., Zahurak, M.L., Daniel, R.W., Viglione, M., Symer, D.E., Shah, K.V., and Sidransky, D. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92(9), 709-720.
128. Ha, P.K., Pai, S.I., Westra, W.H., Gillison, M.L., Tong, B.C., Sidransky, D., and Califano, J.A. (2002) Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin. Cancer Res. 8(5), 1203-1209.
129. Capone, R.B., Pai, S.I., Koch, W.M., Gillison, M.L., Danish, H.N., Westra, W.H., Daniel, R., Shah, K.V., and Sidransky, D. (2000) Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin. Cancer Res. 6(11), 4171-4175.
130. Zhao, M., Rosenbaum, E., Carvalho, A.L., Koch, W., Jiang, W., Sidransky, D., and Califano, J. (2005) Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int. J. Cancer 117(4), 605-610.
131. Asham, E., Shankar, A., Loizidou, M., Fredericks, S., Miller, K., Boulos, P.B., Burnstock, G., and Taylor, I. (2001) Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism. Br. J. Cancer 85(11), 1759-1763.
132. Alanen, K., Deng, D.X., and Chakrabarti, S. (2000) Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma. Histopathology 36(2), 161-167.
133. Ahmed, S.I., Thompson, J., Coulson, J.M., and Woll, P.J. (2000) Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am. J. Respir. Cell Mol. Biol. 22(4), 422-431.
134. Denver, R., Tzanidis, A., Martin, P., and Krum, H. (2000) Salivary endothelin concentrations in the assessment of chronic heart failure. Lancet 355(9202), 468-469.
135. Lam, H.C., Lo, G.H., Lee, J.K., Lu, C.C., Chu, C.H., Sun, C.C., Chuang, M.J, and Wang, M.C. (2004) Salivary immunoreactive endothelin in patients with upper gastrointestinal diseases. J. Cardiovasc. Pharmacol. 44(Suppl 1), S413-S417.
136. Pickering, V., Jordan, R.C., and Schmidt, B.L. (2007) Elevated salivary endothelin levels in oral cancer patients - a pilot study. Oral Oncol. 43(1), 37-41.
137. Lichtenstein, A., Ganz, T., Selsted, M.E., and Lehrer, R.I. (1986) In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood 68(6), 1407-1410.
138. Mizukawa, N., Sugiyama, K., Fukunaga, J., Ueno, T., Mishima, K., Takagi, S., and Sugahara, T. (1998) Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res. 18(6B), 4645-4649. (Pubitemid 29042038)
139. Nagler, R., Bahar, G., Shpitzer, T., and Feinmesser, R. (2006) Concomitant analysis of salivary tumor markers - a new diagnostic tool for oral cancer. Clin. Cancer Res. 12(13), 3979-3984. (Pubitemid 44078083)
140. Coussens, L.M. and Werb, Z. (2002) Inflammation and cancer. Nature 420(6917), 860-867.
141. Katakura, A., Kamiyama, I., Takano, N., Shibahara, T., Muramatsu, T., Ishihara, K., Takagi, R., and Shouno, T. (2007) Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull. Tokyo Dent. Coll. 48(4), 199-203.
142. St John, M.A., Li, Y., Zhou, X., Denny, P., Ho, C.M., Montemagno, C., Shi, W., Qi, F., Wu, B., Sinha, U., Jordan, R., Wolinsky, L., et al.,( 2004) Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 130(8), 929-935. (Pubitemid 39045599)
143. Li, Y., St John, M.A., Zhou, X., Kim, Y., Sinha, U., Jordan, R.C., Eisele, D., Abemayor, E., Elashoff, D., Park, N.H, and Wong, D.T. (2004) Salivary transcriptome diagnostics for oral cancer detection. Clin. Cancer Res. 10(24), 8442-8450. (Pubitemid 40053408)
144. Arellano, M., Jiang, J., Zhou, X., Zhang, L., Ye, H., Wong, D.T., and Hu, S. (2009) Current advances in identification of cancer biomarkers in saliva. Front. Biosci. (Schol. Ed.) 1, 296-303.
145. Friedman, J.M. and Halaas, J.L. (1998) Leptin and the regulation of body weight in mammals. Nature 395(6704), 763-770. (Pubitemid 28485436)
146. Cascio, S., Bartella, V., Auriemma, A., Johannes, G.J., Russo, A., Giordano, A., and Surmacz, E. (2008) Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1alpha. Oncogene 27(4), 540-547.
147. Koda, M., Sulkowska, M., Kanczuga-Koda, L., Surmacz, E., and Sulkowski, S. (2007) Overexpression of the obesity hormone leptin in human colorectal cancer. J. Clin. Pathol. 60(8), 902-906. (Pubitemid 47234437)
148. Schapher, M., Wendler, O., Groschl, M., Schafer, R., Iro, H., and Zenk, J. (2009) Salivary leptin as a candidate diagnostic marker in salivary gland tumors. Clin. Chem. 55(5), 914-922.
149. Clark, S.J. and Melki, J. (2002) DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 21(35), 5380-5387. (Pubitemid 34983474)
150. Herman, J.G. and Baylin, S.B. (2003) Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349(21), 2042-2054. (Pubitemid 37448928)
151. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B., and Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1(7), 686-692.
152. Eads, C.A., Danenberg, K.D., Kawakami, K., Saltz, L.B., Blake, C., Shibata, D., Danenberg, P.V., and Laird, P.W. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28(8), E32.
153. Cottrell, S.E. and Laird, P.W. (2003) Sensitive detection of DNA methylation. Ann. N. Y. Acad. Sci. 983, 120-130.
154. Palmisano, W.A., Divine, K.K., Saccomanno, G., Gilliland, F.D., Baylin, S.B., Herman, J.G., and Belinsky, S.A. (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 60(21), 5954-5958.
155. Rosas, S.L., Koch, W., da Costa Carvalho, M.G., Wu, L., Califano, J., Westra, W., Jen, J., and Sidransky, D. (2001) Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 61(3), 939-942.
156. Nakahara, Y., Shintani, S., Mihara, M., Hino, S., and Hamakawa, H. (2006) Detection of p16 promoter methylation in the serum of oral cancer patients. Int. J. Oral Maxillofac. Surg. 35(4), 362-365. (Pubitemid 43286270)
157. Ishida, E., Nakamura, M., Ikuta, M., Shimada, K., Matsuyoshi, S., Kirita, T., and Konishi, N. (2005) Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma. Oral Oncol. 41(6), 614-622. (Pubitemid 40828879)
158. Uesugi, H., Uzawa, K., Kawasaki, K., Shimada, K., Moriya, T., Tada, A., Shiiba, M., and Tanzawa, H. (2005) Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma. Int. J. Mol. Med. 15(4), 597-602.
159. Carvalho, A.L., Jeronimo, C., Kim, M.M., Henrique, R., Zhang, Z., Hoque,
160. Viet, C.T. and Schmidt, B.L. (2008) Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol. Biomarkers Prev. 17(12), 3603-3611.
161. Sidransky, D. (1995) Molecular markers in cancer diagnosis. J. Natl. Cancer Inst. Monogr. (17), 27-29.
162. Spafford, M.F., Koch, W.M., Reed, A.L., Califano, J.A., Xu, L.H., Eisenberger, C.F., Yip, L., Leong, P.L., Wu, L., Liu, S.X., Jeronimo, C., Westra, W.H., et al. (2001) Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin. Cancer Res. 7(3), 607-612. (Pubitemid 32707986)
163. Hu, S., Arellano, M., Boontheung, P., Wang, J., Zhou, H., Jiang, J., Elashoff, D., Wei, R., Loo, J.A., and Wong, D.T. (2008) Salivary proteomics for oral cancer biomarker discovery. Clin. Cancer Res. 14(19), 6246-6252.
164. Ramachandran, P., Boontheung, P., Xie, Y., Sondej, M., Wong, D.T., and Loo, J.A. (2006) Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J. Proteome Res. 5(6), 1493-1503. (Pubitemid 43865819)
165. Hu, S., Yu, T., Xie, Y., Yang, Y., Li, Y., Zhou, X., Tsung, S., Loo, R.R., Loo, J.R., and Wong, D.T. (2007) Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genom. Proteom. 4(2), 55-64. (Pubitemid 46632026)
166. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P., and Burge, C.B. (2003) Prediction of mammalian microRNA targets. Cell 115(7), 787-798.
167. Humphreys, D.T., Westman, B.J., Martin, D.I., and Preiss, T. (2005) MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc. Natl. Acad. Sci. U. S. A. 102(47), 16961-16966.
168. Wakiyama, M., Takimoto, K., Ohara, O., and Yokoyama, S. (2007) Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system. Genes Dev. 21(15), 1857-1862. (Pubitemid 47204925)
169. Zhang, X., Cairns, M., Rose, B., O'Brien, C., Shannon, K., Clark, J., Gamble, J., and Tran, N. (2009) Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int. J. Cancer 124(12), 2855-2863.
170. Tricoli, J.V. and Jacobson, J.W. (2007) MicroRNA: potential for cancer detection, diagnosis, and prognosis. Cancer Res. 67(10), 4553-4555. (Pubitemid 46910157)
171. Mandel, I.D. (1993) Salivary diagnosis: promises, promises. Ann. N. Y. Acad. Sci. 694, 1-10.
172. Miller, S.M. (1994) Saliva testing - a non-traditional diagnostic tool. Clin. Lab. Sci. 7(1), 39-44.
173. Hu, S., Xie, Y., Ramachandran, P., Ogorzalek Loo, R.R., Li, Y., Loo, J.A., and Wong, D.T. (2005) Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 5(6), 1714-1728. (Pubitemid 40593277)
174. Li, Y., Zhou, X., St John, M.A., and Wong, D.T. (2004) RNA profiling of cell-free saliva using microarray technology. J. Dent. Res. 83(3), 199-203. (Pubitemid 41715238)
175. Li, Y., Elashoff, D., Oh, M., Sinha, U., St John, M.A., Zhou, X., Abemayor, E., and Wong, D.T. (2006) Serum circulating human mRNA profiling and its utility for oral cancer detection. J. Clin. Oncol. 24(11), 1754-1760. (Pubitemid 46622147)
176. Segal, A. and Wong, D.T. (2008) Salivary diagnostics: enhancing disease detection and making medicine better. Eur. J. Dent. Educ. 12(Suppl 1), 22-29.
177. Gau, V. and Wong, D. (2007) Oral fluid nanosensor test (OFNASET) with advanced electrochemical-based molecular analysis platform. Ann. N. Y. Acad. Sci. 1098, 401-410. (Pubitemid 47092526)
178. Streckfus, C., Bigler, L., Tucci, M., and Thigpen, J.T. (2000) A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer. Invest. 18(2), 101-109. (Pubitemid 30118402)
179. Streckfus, C. and Bigler, L. (2005) The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study. Adv. Dent. Res. 18(1), 17-24.
180. Chen, D.X., Schwartz, P.E., Li, X.G., and Yang, Z. (1988) Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses. Obstet. Gynecol. 72(1), 23-27.
181. Cornélissen, G., Halberg, F., Halberg, E., Bingham, C., Haus, E., Bast, R.C., Jr., Fujii, S., Long, H.J., 3rd, Halberg, F., and Tamura, K. (1992) Toward a chronotherapy of ovarian cancer. Part III: Salivary CA125 for chronochemotherapy by efficacy. Chronobiology 19(3-4), 131-149.
182. Navarro, M.A., Mesía, R., Díez-Gibert, O., Rueda, A., Ojeda, B., and Alonso, M.C. (1997) Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women. Breast Cancer Res. Treat. 42(1), 83-86. (Pubitemid 27056731)
183. Sephton, S.E., Sapolsky, R.M., Kraemer, H.C., and Spiegel, D. (2000) Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 92(12), 994-1000.
184. Eguchi, J., Ishihara, K., Watanabe, A., Fukumoto, Y., and Okuda, K. (2003) PCR method is essential for detecting Mycobacterium tuberculosis in oral cavity samples. Oral Microbiol. Immunol. 18(3), 156-159.
185. Tiwari, S.K., Khan, A.A., Ahmed, K.S., Ahmed, I., Kauser, F., Hussain, M.A., Ali, S.M., Alvi, A., Habeeb, A., Abid, Z., Ahmed, N., and Habibullah, C.M. (2005) Rapid diagnosis of Helicobacter pylori infection in dyspeptic patients using salivary secretion: a non-invasive approach. Singapore Med. J. 46(5), 224-228.
186. Ahmed, K.S., Khan, A.A., Ahmed, I., Tiwari, S.K., Habeeb, M.A., Ali, S.M., Ahi, J.D., Abid, Z., Alvi, A., Hussain, M.A., Ahmed, N., and Habibullah, C.M. (2006) Prevalence study to elucidate the transmission pathways of Helicobacter pylori at oral and gastroduodenal sites of a South Indian population. Singapore Med. J. 47(4), 291-296.
187. Malamud, D. (1992) Saliva as a diagnostic fluid. BMJ 305(6847), 207-208.
188. Matsuda, S., Oka, S., Honda, M., Takebe, Y., and Takemori, T. (1993) Characteristics of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages. Scand. J. Immunol. 38(5), 428-434.
189. Ly, T.D., Ebel, A., Faucher, V., Fihman, V., and Laperche, S. (2007) Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J. Virol. Methods 143(1), 86-94.
190. Liuzzi, G., Chirianni, A., Clementi, M., Zaccarelli, M., Antinori, A., and Piazza, M. (2002) Reduction of HIV-1 viral load in saliva by indinavir-containing antiretroviral regimen. AIDS 16(3), 503-504.
191. Bourlet, T., Cazorla, C., Berthelot, P., Grattard, F., Cognasse, F., Fresard, A., Defontaine, C., Lucht, F.R., Genin, C., and Pozzetto, B. (2001) Compartmentalization of HIV-1 according to antiretroviral therapy: viral loads are correlated in blood and semen but poorly in blood and saliva. AIDS 15(2), 284-285.
192. Ho, D.D., Byington, R.E., Schooley, R.T., Flynn, T., Rota, T.R., and Hirsch, M.S. (1985) Infrequency of isolation of HTLV-III virus from saliva in AIDS. N. Engl. J. Med. 313(25), 1606.
193. Cameron, J.E., Snowhite, I.V., Chaturvedi, A.K., and Hagensee, M.E. (2003) Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals. Clin. Diagn. Lab. Immunol. 10(3), 431-438.
194. Gautheret, A., Aubin, J.T., Fauveau, V., Rozenbaum, W., Huraux, J.M., and Agut, H. (1995) Rate of detection of human herpesvirus-6 at different stages of HIV infection. Eur. J. Clin. Microbiol. Infect. Dis. 14(9), 820-824.
195. Furuta, Y., Fukuda, S., Chida, E., Takasu, T., Ohtani, F., Inuyama, Y., and Nagashima, K. (1998) Reactivation of herpes simplex virus type 1 in patients with Bell's palsy. J. Med. Virol. 54(3), 162-166.
196. Blackbourn, D.J., Lennette, E.T., Ambroziak, J., Mourich, D.V., and Levy, J.A. (1998) Human herpesvirus 8 detection in nasal secretions and saliva. J. Infect. Dis. 177(1), 213-216.
197. Oliveira, S.A., Siqueira, M.M., Camacho, L.A., Castro-Silva, R., Bruno, B.F., and Cohen, B.J. (2003) Use of RT-PCR on oral fluid samples to assist the identification of measles cases during an outbreak. Epidemiol. Infect. 130(1), 101-106.
198. Jin, L., Feng, Y., Parry, R., Cui, A., and Lu, Y. (2007) Real-time PCR and its application to mumps rapid diagnosis. J. Med. Virol. 79(11), 1761-1767.
199. Drosten, C., Doerr, H.W., Lim, W., Stöhr, K., and Niedrig, M. (2004) SARS molecular detection external quality assurance. Emerg. Infect. Dis. 10(12), 2200-2203.
200. Crepin, P., Audry, L., Rotivel, Y., Gacoin, A., Caroff, C., and Bourhy, H. (1998) Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J. Clin. Microbiol. 36(4), 1117-1121.
201. Formenty, P., Leroy, E.M., Epelboin, A., Libama, F., Lenzi, M., Sudeck, H., Yaba, P., Allarangar, Y., Boumandouki, P., Nkounkou, V.B., Drosten, C., Grolla, A., Feldmann, H., and Roth, C. (2006) Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin. Infect. Dis. 42(11), 1521-1526.
202. Ksiazek, T.G., Rollin, P.E., Williams, A.J., Bressler, D.S., Martin, M.L., Swanepoel, R., Burt, F.J., Leman, P.A., Khan, A.S., Rowe, A.K., Mukunu, R., Sanchez, A., and Peters, C.J. (1999) Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo. J. Infect. Dis. 179(Suppl 1), S177-S187.
203. Friedman, J.M. and Halaas, J.L. (1998) Leptin and the regulation of body weight in mammals. Nature 395(6704), 763-770.
204. Faraj, M., Havel, P.J., Phélis, S., Blank, D., Sniderman, A.D., and Cianflone, K. (2003). Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J. Clin. Endocrinol. Metab. 88(4), 1594-1602.
205. Toda, M., Tsukinoki, R., and Morimoto, K. (2007) Measurement of salivary adiponectin levels. Acta Diabetol. 44(1), 20-22.
206. Toda, M. and Morimoto, K. (2008) Comparison of saliva sampling methods for measurement of salivary adiponectin levels. Scand. J. Clin. Lab. Invest. 68(8), 823-825.
207. Gröschl, M., Rauh, M., Wagner, R., Neuhuber, W., Metzler, M., Tamgüney, G., Zenk, J., Schoof, E., Dörr, H.G., Blum, W.F., Rascher, W., and Dötsch, J. (2001) Identification of leptin in human saliva. J. Clin. Endocrinol. Metab. 86(11), 5234-5239.
208. Randeva, H.S., Karteris, E., Lewandowski, K.C., Sailesh, S., O'Hare, P., and Hillhouse, E.W. (2003) Circadian rhythmicity of salivary leptin in healthy subjects. Mol. Genet. Metab. 78(3), 229-235.
209. Schapher, M., Wendler, O., Gröschl, M., Schäfer, R., Iro, H., and Zenk, J. (2009) Salivary leptin as a candidate diagnostic marker in salivary gland tumors. Clin. Chem. 55(5), 914-922.
210. Aydin, S., Halifeoglu, I., Ozercan, I.H., Erman, F., Kilic, N., Aydin, S., Ilhan, N., Ilhan, N., Ozkan, Y., Akpolat, N., Sert, L., and Caylak, E.A. (2005) Comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects. Peptides 26(4), 647-652.
211. Turner, M. and Ship, J.A. (2008) Salivary secretion in health and disease. In Salivary Diagnostics. Wong, D.T., Ed. Wiley-Blackwell. Chap. 5.
212. Smith, R.G. and Burtner, A.P. (1994) Oral side-effects of the most frequently prescribed drugs. Spec. Care Dentist. 14, 96-102.
213. (2003) Centres for Disease Control and Prevention. Public health and ageing: trends in ageing - United States and Worldwide. JAMA 289, 1371-1373.
214. Ship, J.A. and Pimmemer, S.R. (2002) Xerostomis and the geriatric patient. J. Am. Geriatr. Soc. 50, 535-543.
215. Porter, S.R., Scully, C., and Hegarty, A.M. (2004) An update of the etiology and management of xerostomia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 97, 28-46.
216. Shiboski, C.H., Hodgeson, T.A. Ship, J.A., and Schiodt, M. (2007) Management of salivary hypofunction during and after radiotherapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 103(Suppl), S66.e1-19.
217. Pillemer, S.R., Matteson, E.L., Jacobsson, L.T., Martens, P.B., Melton, L.J., 3rd, O'Fallon, W.M., and Fox, P.C. (2001) Incidence of physician-diagnosed primary Sjögren's syndrome in residents of Olmsted County, Minnesota. Mayo Clin. Proc. 76, 593-599.
218. Renshaw, D., Mancini, L., Flower, R., and Perretti, M. (2008) Salivary cortisol: a possible regulator of salivary annexin 1. Endocrine Abstracts 15 P330.